Jounce Therapeutics, Inc. Common Stock
|Range Today||$20.90 - $23.07|
|52 Week Range||$11.05 - $29.29|
Jounce Therapeutics, Inc. develops and manufactures drugs and immunotherapies. It produces cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber and Padmanee Sharmain in 2013 and is headquartered in Cambridge, MA.